Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cytochrome P450 reconstitution systems.

Hiroshi Yamazaki1, Tsutomu Shimada

  • 1Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, Machida, Tokyo, Japan.

Methods in Molecular Biology (Clifton, N.J.)
|May 25, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Feasibility of physiologically based pharmacokinetic simulations for assessing pediatric patients after accidental drug ingestion: A case study of a 1.4-year-old girl who ingested alprazolam.

Drug metabolism and pharmacokinetics·2021
Same author

Impact of nitrogen compound variability of sewage treated water on N<sub>2</sub>O production in riverbeds.

Journal of environmental management·2021
Same author

Genetic variants of flavin-containing monooxygenase 3 (FMO3) in Japanese subjects identified by phenotyping for trimethylaminuria and found in a database of genome resources.

Drug metabolism and pharmacokinetics·2021
Same author

Hepatotoxicological potential of <i>P</i>-toluic acid in humanised-liver mice investigated using simplified physiologically based pharmacokinetic models.

Xenobiotica; the fate of foreign compounds in biological systems·2021
Same author

Evaluation of domain of unknown function 1220 (DUF1220) for detection of human genome by quantitative polymerase chain reaction: Potential use in assessing the biodistribution of transplanted therapeutic human cells.

Drug metabolism and pharmacokinetics·2021
Same author

Associations between Socioeconomic Status, Social Participation, and Physical Activity in Older People during the COVID-19 Pandemic: A Cross-Sectional Study in a Northern Japanese City.

International journal of environmental research and public health·2021

Optimizing cytochrome P450 (CYP) activity reconstitution is crucial for understanding drug metabolism. This study details optimal conditions for reconstituting key human CYP enzymes, including CYP1A2, 2C9, 2E1, and 3A4, for accurate research.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Drug Metabolism

Background:

  • Human liver microsomes contain multiple cytochrome P450 (CYP) enzymes responsible for xenobiotic and endobiotic chemical oxidation.
  • Individual CYP forms exhibit unique yet overlapping substrate specificities, necessitating identification of key enzymes in chemical metabolism.
  • Reconstitution of CYP activities using purified enzymes and reductase in phospholipid vesicles is a valuable research method.

Purpose of the Study:

  • To determine optimal conditions for reconstituting drug oxidation activities of specific human CYP enzymes.
  • To address variability in reconstitution conditions dependent on the P450 enzyme used.
  • To provide a framework for studying the roles of individual CYPs in chemical metabolism.

Main Methods:

Related Experiment Videos

  • Purification of key human CYP enzymes (CYP1A2, 2C9, 2E1, and 3A4).
  • Reconstitution of enzymatic activity by mixing purified CYPs, nicotinamide adenine dinucleotide phosphate-cytochrome P450 reductase, and phospholipids in vesicles.
  • Optimization of reconstitution conditions, including the potential requirement for cytochrome-b5 and specific phospholipid environments.

    • Main Results:

    • Identified varying optimal conditions for reconstituting different human CYP enzymes.
    • Demonstrated that some CYP-catalyzed reactions require cytochrome-b5 and specific phospholipid environments for maximal activity.
    • Established optimized protocols for reconstituting drug oxidation activities of CYP1A2, 2C9, 2E1, and 3A4.

    Conclusions:

    • Optimal reconstitution conditions are enzyme-specific for human CYPs.
    • Cytochrome-b5 and phospholipid composition significantly influence CYP catalytic activity.
    • The described methods facilitate accurate investigation of drug metabolism by specific human CYP isoforms.